Immunome Inc (IMNM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -212,394 | -292,963 | -106,806 | -36,896 | -24,711 |
| Depreciation Amortization | 116 | -797 | 216 | 631 | 755 |
| Accounts payable and accrued liabilities | -9,164 | 9,526 | -608 | -677 | 1,780 |
| Other Working Capital | -15,227 | 14,874 | 11,997 | 2,243 | 2,778 |
| Other Operating Activity | 45,750 | 158,566 | 87,633 | 6,009 | 1,172 |
| Operating Cash Flow | $-190,919 | $-110,794 | $-7,568 | $-28,690 | $-18,226 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 76,734 | -31,555 | -38,929 | N/A | N/A |
| PPE Investments | -9,685 | -7,173 | -831 | -248 | -79 |
| Net Acquisitions | N/A | N/A | 9,276 | N/A | N/A |
| Other Investing Activity | -6,246 | -46,335 | 0 | 0 | 0 |
| Investing Cash Flow | $60,803 | $-85,063 | $-30,484 | $-248 | $-79 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | N/A | -113 |
| Common Stock Issued | 679,813 | 255,757 | 405 | 32 | 28,662 |
| Other Financing Activity | -39,456 | -15,228 | 116,003 | 0 | -781 |
| Financing Cash Flow | $640,357 | $240,529 | $116,408 | $32 | $27,768 |
| Beginning Cash Position | 143,451 | 98,779 | 20,423 | 49,329 | 39,866 |
| End Cash Position | 653,692 | 143,451 | 98,779 | 20,423 | 49,329 |
| Net Cash Flow | $510,241 | $44,672 | $78,356 | $-28,906 | $9,463 |
| Free Cash Flow | |||||
| Operating Cash Flow | -190,919 | -110,794 | -7,568 | -28,690 | -18,226 |
| Capital Expenditure | -9,685 | -7,173 | -831 | -248 | -79 |
| Free Cash Flow | -200,604 | -117,967 | -8,399 | -28,938 | -18,305 |